GlassScriptPhysician profile
Aaron Poliak
NPI 1700405362
$3,866.35
in general payments reported to CMS, 2019-2025
10 companies · $429 in 2025
The $429 reported for 2025 was more than what 76% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $63.30 · 2023: $144 · 2024: $3,230 · 2025: $429.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,498 · Food and Beverage: $1,305.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,497.76 |
| Food and Beverage | $1,305.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Highridge Medical LLC | $1,794.36 | 2024 | The Tether |
| Globus Medical, INC. | $965.14 | 2024 | Xlif, Reline, Creo 5.5 |
| Stryker Corporation | $740.68 | 2022-2025 | Mako, Variax, Gamma |
| Medtronic, INC. | $109.72 | 2025 | Unid_pass |
| Zimmer Biomet Holdings, INC. | $72.21 | 2024 | Persona, Comprehensive Shoulder System |
| Si-Bone, INC. | $66.52 | 2024 | |
| Kci USA, INC. | $38.12 | 2023 | V.A.C. Veraflo Cleanse Choice, Bair Paws, Ranger |
| Vertex Pharmaceuticals Incorporated | $28.79 | 2025 | |
| Pacira Pharmaceuticals Incorporated | $25.78 | 2025 | Exparel |
| Rock Medical Orthopedics, INC. | $25.03 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Aaron Poliak listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.